✦ LIBER ✦

Eortc-gimema AML8 protocol. Parallel phase III trials in acute myelogenous leukemia (AML)

✍ Scribed by Zittoun, R.; Mandelli, F.

Book ID: 123059715
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 162 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91450-Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-infusional vs intravenous consolidat

Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial

✍ Jehn, U; Suciu, S; Thomas, X; Lefrère, F; Muus, P; Berneman, Z; Marie, J-P; Adam 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB

162. Phase II clinical trial with hexame

162. Phase II clinical trial with hexamethylene bisacetamide (HMBA) in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML)

✍ Michaeli, J; Andreeff, M; Stone, R; Young, CL; Kufe, D; Rifkind, RA; Marks, Pa 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Quality of life in patients with acute m

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

✍ Zittoun, R; Suciu, S; Watson, M; Solbu, G; Muus, P; Mandelli, F; Stryckmans, P; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Centre effect on treatment outcome for p

Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA

✍ S. Keating; T. de Witte; S. Suciu; F. Mandelli; E. Damasio; R. Willemze; E. Morr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Sequential Combination of Gemtuzumab Ozo

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

✍ Amadori, S.; Suciu, S.; Stasi, R.; Salih, H. R.; Selleslag, D.; Muus, P.; De Fab 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 249 KB